Breast Cancer Clinical Trials

Find Breast Cancer Clinical Trials Near You

Analysis of Anatomical Parameters in the Radiotherapy of Breast Cancer

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Prospective observational study. The purpose of this project is to identify a parameter system that will allow to identify a priori the most appropriate radiotherapy technique for each patient undergoing breast radiotherapy at our center. All patients will be treated and monitored according to the local clinical practice. A total of at least 30 patients will be included in the study. Dose prescription will be 40.05 Gy (Gray) in 15 fractions. For each patient, 3 RT treatment plans will be simulated: Three-Dimensional Conformal Radiation Therapy (3D-CRT), Step-and-shoot intensity-modulated radiotherapy (IMRT S\&S), and hybrid technique (3D-CRT+IMRT). A total of 90 plans will be available. The best treatment technique will be chosen based on scoring provided by at least 3 expert clinicians. The primal plan choice will be the one with higher total rate, evaluated as a sum of 3 single rates.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Female

• Target volume: left breast

• Tumor type: any diagnosis of breast cancer

• Dose prescription: 40.05 Gray/15 fractions

• Patients aged ≥ 18 years old

• Patients willing and able to give informed consent to participate

Locations
Other Locations
Italy
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST IRCCS
RECRUITING
Meldola
Contact Information
Primary
Oriana Nanni
oriana.nanni@irst.emr.it
Backup
Bernadette Vertogen
bernadette.vertogen@irst.emr.it
Time Frame
Start Date: 2023-06-16
Estimated Completion Date: 2026-12
Participants
Target number of participants: 30
Treatments
Patients treated for breast cancer at IRST IRCCS Radiotherapy Facility
Consecutive patients treated for breast cancer (on the left breast) at Radiotherapy Facility of IRCCS IRST in Meldola (FC, Italy)
Related Therapeutic Areas
Sponsors
Leads: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

This content was sourced from clinicaltrials.gov